Korea Biomedical Review is publishing a series of interview articles highlighting the most influential female executives in the Korean biotech and biopharma industry. This is the second installment. -- Ed.Inspired by her dad who was a doctor, the International Vaccine Institute’s (IVI) seasoned vacc
Korea Biomedical Review is publishing a series of interview articles highlighting the most influential female executives in the Korean biotech and biopharma industry. This is the first installment. -- Ed.With a career spanning medicine, academia, clinical research, and now executive management, it’s
Korea Biomedical Review is publishing a series of articles to analyze the top 10 Korean pharmaceutical and biopharma companies with the largest market capitalizations listed on the main bourse, Kospi, and the tech-heavy Kosdaq. The series aims to reflect key industrial issues and the flow of the cap
The Covid-19 pandemic laid the foundation for the commercialization of the mRNA platform which pharmaceutical companies are now investing heavily. Not to be left out of the action, Sanofi also announced its new Translational Science Hub in Australia in December which will link to its mRNA Centre of
Korea has a very complicated drug pricing policy and the government should allow pharmaceutical companies to access review data for reimbursement, Eli Lilly Korea’s leader said.Eli Lilly, a multinational pharmaceutical company approaching its 150th anniversary, appointed Christopher J. Stokes to lea
Despite the hype surrounding nasal vaccines recently, they are not new really a new concept. These vaccines came back on the radar after Bharat Biotech’s Incovac was recently launched as a two-dose regimen for primary vaccinations and a booster dose in India on Jan. 26.In fact, nasal vaccines agains
With fierce competition among dermatologists, many clinics have resorted to lowering prices to attract customers for botulinum toxin (BTX) procedures in Korea. Searches for “5,000-won ($4) Botox” on Naver lead to hundreds of blogs introducing low-cost BTX shots available in Gangnam, the southern par
As Covid-19 exited the spotlight, it made way for other seasonal viruses like norovirus. Despite limited monitoring for this virus, cases have still been surging compared to previous years.The U.K. noted a 66 percent increase in cases compared to the average caseload at this time of year. The U.S. h
While Medytox and Daewoong have been embroiled in court matters over the source of a botulinum toxin (BTX) strain, from the consumer’s perspective, a growing issue of concern is resistance to BTX.It is no secret that Korea has a large BTX market driven by its high emphasis on beauty standards. In No
Recently designated as an innovative pharmaceutical company by the Ministry of Health and Welfare, Bridge Biotherapeutics has already joined forces with Pinotbio to develop ADC cancer drug candidates, displaying its tenacity to pursue novel drugs.Bridge Biotherapeutics' Business Development Director
Though it is not just Korea feeling the sting of low investor sentiment in the bioindustry, it is clear that swift government intervention is crucial to help refuel investment in Korea’s bioindustry.The Korean government provides incentives such as tax support, eased rules in building R&D facilities
As one of the largest investors in research and development, Roche Diagnostics revealed plans to tackle tuberculosis (TB) which remains a pressing issue for the Asian region. The diagnostic giant also recently joined forces with the Korea Health Industry Development Institute (KHIDI) to cooperate on
Nu Eyne, a Korean healthcare start-up, was recently selected by the Ministry of Health and Welfare (MOHW) to develop bioelectronic medicine technology for the first Health and Medical Technology R&D project. The start-up began in 2017 with just four founding members but has since grown, with an on-s
The wide realm of possibilities for using ChatGPT are expanding ever since the platform went public in the latter half of last year. The generative artificial intelligence (AI)-based platform most recently passed the United States Medical License Exam (USMLE) and improved zinc finger nucleases (ZFNs